{"ORPHApacket":[{"ORPHApacketID":"2297","date":"2019-12-05 19:58:54","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"2297","Name":[{"lang":"en","label":"Insulin-resistance syndrome type A"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_2297","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare insulin-resistance syndrome"}],"ORPHA":"181368","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_181368"},{"Name":[{"lang":"en","label":"Rare female infertility due to an anomaly of ovarian function of genetic origin"}],"ORPHA":"400022","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_400022"},{"Name":[{"lang":"en","label":"Rare female infertility due to an anomaly of ovarian function"}],"ORPHA":"399853","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_399853"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Type A insulin-resistance syndrome belongs to the group of extreme insulin-resistance syndromes (which includes leprechaunism, the lipodystrophies, Rabson-Mendenhall syndrome and type B insulin resistance syndrome; see these terms) and is characterized by the triad of hyperinsulinemia, acanthosis nigricans (skin lesions associated with insulin resistance), and signs of hyperandrogenism in females without lipodystrophy and who are not overweight."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"610549","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]},{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"insulin receptor"}],"Symbol":"INSR","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"OMIM","Reference":"147670"},{"Source":"HGNC","Reference":"6091"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"7","HPODisorderAssociation":[{"HPOId":"HP:0000823","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000823","HPOTerm":"Delayed puberty","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0000962","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000962","HPOTerm":"Hyperkeratosis","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0001482","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001482","HPOTerm":"Subcutaneous nodule","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002230","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002230","HPOTerm":"Generalized hirsutism","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0005616","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0005616","HPOTerm":"Accelerated skeletal maturation","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0005978","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0005978","HPOTerm":"Type II diabetes mellitus","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0007440","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0007440","HPOTerm":"Generalized hyperpigmentation","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}